Important results presented during the opening ceremony #ISICEM23!
@ISICEM
✅ Hydrocortisone reduces mortality in sCAP (bit.ly/3ZbqHUc)
✅ Ravulizumab did not improve survival or other key outcomes in patients hospitalised with severe COVID-19 (bit.ly/3JVDdTm)
@ISICEM
✅ Hydrocortisone reduces mortality in sCAP (bit.ly/3ZbqHUc)
✅ Ravulizumab did not improve survival or other key outcomes in patients hospitalised with severe COVID-19 (bit.ly/3JVDdTm)
✅ no benefit in PCC administration in trauma patients at risk of massive transfusion (bit.ly/3Jvu7va)
✅ therapeutic-dose heparin: beneficial in hospitalized C19 patients less severely ill at presentation or lower body mass index (bit.ly/3Jq1uiE)
(2/3)
✅ therapeutic-dose heparin: beneficial in hospitalized C19 patients less severely ill at presentation or lower body mass index (bit.ly/3Jq1uiE)
(2/3)
✅ Low-calorie low-protein feeding (acute phase of critical illness): Faster recovery, fewer complications (bit.ly/3TtMg0X)
✅ In the absence of early parenteral nutrition, tight glucose control did not reduce duration of ICU dependency.
(3/3)
✅ In the absence of early parenteral nutrition, tight glucose control did not reduce duration of ICU dependency.
(3/3)
@giovannilandoni we have some links here!
• • •
Missing some Tweet in this thread? You can try to
force a refresh
